Browsing: FDA approval News

FDA approves Zanvastro, the first Alexander disease treatment, from Ionis Pharmaceuticals – but shares barely move on the news.

The FDA’s pancreatic cancer drug approval for Revolution Medicines’ daraxonrasib lands months early, but the stock barely moved. Here’s why.

Abbott’s Libre Duo 10 Day wins FDA authorisation as the first dual glucose-ketone sensor, opening a new front in diabetes-tech competition.

Alesi Surgical, a Cardiff-based medtech company, is poised for significant global expansion following a successful £5 million equity increase led by Mercia Ventures.The company specialises in…

neuroClues, a leading medtech startup, has secured €5 million in its latest funding initiative. This development aims to enhance their innovative eye-tracking technology.Eye movements reveal underlying…